ARCHIVES

Health Professional Training Needs Improvement, IOM Says.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Shared Specimen Resource Needed, GYN Review Finds.

February 1, 2002

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

March 1, 1996

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007